Appendix B to Subpart G of Part 1—List of Modified Nucleotides
Source: World Intellectual Property Organization (WIPO) Handbook on Industrial Property Information and Documentation, Standard ST.25: Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings in Patent Applications (2009).
| Symbol | Meaning |
|---|---|
| ac4c | 4-acetylcytidine. |
| chm5u | 5-(carboxyhydroxymethyl)uridine. |
| cm | 2′-O-methylcytidine. |
| cmnm5s2u | 5-carboxymethylaminomethyl-2-thiouridine. |
| cmnm5u | 5-carboxymethylaminomethyluridine. |
| d | dihydrouridine. |
| fm | 2′-O-methylpseudouridine. |
| gal q | beta, D-galactosylqueuosine. |
| gm | 2′-O-methylguanosine. |
| i | inosine. |
| i6a | N6-isopentenyladenosine. |
| m1a | 1-methyladenosine. |
| m1f | 1-methylpseudouridine. |
| m1g | 1-methylguanosine. |
| m1i | 1-methylinosine. |
| m22g | 2,2-dimethylguanosine. |
| m2a | 2-methyladenosine. |
| m2g | 2-methylguanosine. |
| m3c | 3-methylcytidine. |
| m5c | 5-methylcytidine. |
| m6a | N6-methyladenosine. |
| m7g | 7-methylguanosine. |
| mam5u | 5-methylaminomethyluridine. |
| mam5s2u | 5-methoxyaminomethyl-2-thiouridine. |
| man q | beta, D-mannosylqueuosine. |
| mcm5s2u | 5-methoxycarbonylmethyl-2-thiouridine. |
| mcm5u | 5-methoxycarbonylmethyluridine. |
| mo5u | 5-methoxyuridine. |
| ms2i6a | 2-methylthio-N6-isopentenyladenosine. |
| ms2t6a | N-((9-beta-D-ribofuranosyl-2-methylthiopurine-6-yl)carbamoyl)threonine. |
| mt6a | N-((9-beta-D-ribofuranosylpurine-6-yl)N-methylcarbamoyl)threonine. |
| mv | uridine-5-oxyacetic acid-methylester. |
| o5u | uridine-5-oxyacetic acid. |
| osyw | wybutoxosine. |
| p | pseudouridine. |
| q | queuosine. |
| s2c | 2-thiocytidine. |
| s2t | 5-methyl-2-thiouridine. |
| s2u | 2-thiouridine. |
| s4u | 4-thiouridine. |
| t | 5-methyluridine. |
| t6a | N-((9-beta-D-ribofuranosylpurine-6-yl)-carbamoyl)threonine. |
| tm | 2′-O-methyl-5-methyluridine. |
| um | 2′-O-methyluridine. |
| yw | wybutosine. |
| x | 3-(3-amino-3-carboxy-propyl)uridine, (acp3)u. |
[86 FR 57052, Oct. 14, 2021]